Tag: FIRST-IN-HUMAN

Xeltis presents “promising” first-in-human data on restorative haemodialysis access graft

Xeltis today announced what it describes as “very promising” preliminary efficacy and safety results from one of the centres participating in the AXESS study—a...
magneto

Magneto Thrombectomy Solutions announces successful first-in-human results for treatment of pulmonary...

Magneto Thrombectomy Solutions (Magneto), a medical devices company developing thrombectomy solutions for the treatment of ischaemic stroke and pulmonary embolism, presented successful first-in-human (FIH)...
instylla

Instylla first-in-human clinical trial published results demonstrate success

A prospective multicentre study has evaluated the safety and efficacy of a polyethylene glycol (PEG)-based liquid embolic in treating hypervascular tumours, according to an...
wrapsody first study

“Very encouraging” 12-month data from WRAPSODY FIRST study presented at CIRSE...

Twelve-month results from a first-in-human study of the Wrapsody cell-impermeable endoprosthesis (Merit Medical Systems) for the treatment of access circuit stenosis in haemodialysis patients...
stem cell

Promising first-time data indicate human stem cell trial is safe, prompting...

A first-in-human, phase I clinical trial using stem cells to prevent venous stenosis formation in arteriovenous (AV) fistulas yields promising results. Sanjay Misra (Mayo...